Bevacizumab cancer treatment

Bevacizumab cancer treatment

M625/1716 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.8MB

Downloadable file size: 1.4MB

Price image Pricing

Please login to use the price calculator


Credit: BSIP, LOUISE OLIGNY/SCIENCE PHOTO LIBRARY

Caption: Bevacizumab. Doctor drawing a syringe of bevacizumab (Avastin), a monoclonal antibody used in metastatic cancer treatment; for cancers that have spread beyond their original site. It works by targetting and inhibiting the vascular endothelial growth factor (VEGF), thereby preventing tumour growth by blocking the formation of new blood vessels (angiogenesis). Photographed in France.

Release details: Model release not available. Property release not required.

Keywords: adult, angiogenesis, angiogenesis inhibitor, avastin, bevacizumab, black, blocking, blocks, bowel cancer, cancer treatment, doctor, drawing, drug, equipment, europe, european, female, filling, france, glove, gloved hands, gloves, healthcare, hospital, human, inhibiting, inhibits, kidney cancer, mask, masked, medical, medicine, metastatic cancer, monoclonal antibody, nurse, oncology, people, person, pharmaceutic, pharmaceutical, pharmacological, pharmacology, preventing, prevents, syringe, targets, targetting, treatment, vascular endothelial growth factor, vegf, woman

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.